dihydroergotamine has been researched along with tubocurarine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Bisgard, GE; Herbert, DA; Mitchell, RA | 1 |
2 other study(ies) available for dihydroergotamine and tubocurarine
| Article | Year |
|---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Effects of dopamine, norepinephrine and 5-hydroxytryptamine on the carotid body of the dog.
Topics: Animals; Apomorphine; Carotid Body; Dihydroergotamine; Dogs; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Norepinephrine; Serotonin; Stimulation, Chemical; Tubocurarine | 1979 |